Comparing pain relief from two medications after knee surgery
Official title: Comparison Efficacy of Mirogabalin and Pregabalin in Total Knee Arthroplasty. a Randomized Controlled Trial
Run by Thammasat University Hospital · NCT06328062 · Data updated 2026-11-12
This study tests whether mirogabalin or pregabalin works better to relieve pain after knee surgery for people aged 50-85 with osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 85 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Thammasat University Hospital Academic / other |
| Locations | 1 site (Khlong Luang, Changwat Pathum Thani) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | August 31, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | August 7, 2026 |
| Trial ID | NCT06328062 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 50-85 who are undergoing unilateral primary total knee arthroplasty due to osteoarthritis.
✕Probably not a fit
Patients with a glomerular filtration rate below 60, severe liver disease, or those who have had previous knee surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of two medications, mirogabalin and pregabalin, in reducing postoperative pain following unilateral primary total knee arthroplasty (TKA). Participants aged 50-85 with osteoarthritis will be randomly assigned to receive either mirogabalin or pregabalin for six weeks post-surgery. The study will evaluate pain levels and functional outcomes to determine which medication provides better pain relief after the procedure.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management options for patients undergoing knee surgery.
How similar studies have gone: Previous studies have shown promising results in pain management with gabapentinoids, making this approach a potentially valuable addition to postoperative care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 50-85 years old 2. Unilateral primary osteoarthritis undergoing primary TKA 3. ASA I-III Exclusion Criteria: 1. GFR \<60 2. Allergy to drug in this study 3. Cannot underwent spinal anesthesia and adductor canal block 4. Taking gabapentinoid within 3 months before surgery 5. History of previous knee surgery 6. Severe liver disease
Where it's running
-
Thammasat University Hospital
Khlong Luang, Changwat Pathum Thani, Thailand Recruiting
Study contacts
- Study coordinator: Yot Tanariyakul, M.D.
- Email: y.tanariyakul@gmail.com
- Phone: +66863930257
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Choose to Move Replacement Ready for people waiting for hip or knee replacement
This project will test whether the Choose to Move Replacement Ready program helps older adults on hip or knee replacement waitlists increase physical activity, improve mobility, and support psychosocial health.
-
Comparing two knee replacement techniques for better outcomes
This study is testing two different knee replacement techniques to see which one helps people with knee osteoarthritis feel better and move more easily after surgery.
-
Different doses of liposomal bupivacaine for adductor canal block after total knee replacement
This will test whether different doses of liposomal bupivacaine given in the adductor canal block reduce pain and opioid use after elective total knee replacement in adults.
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Mind mapping-based education to help after knee replacement
A group of adults having total knee replacement will receive mind-mapping education in addition to standard care to see if it helps with pain, fear of movement, and readiness to leave the hospital.
-
DoACs vs LMWH for blood flow after knee replacement
This study tests whether rivaroxaban, apixaban, or LMWH work differently to support blood flow in the legs after total knee replacement in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.